Ensign Peak Advisors, Inc - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.

Quarter-by-quarter ownership
Ensign Peak Advisors, Inc ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$131,000
+23.6%
8,210
+6.2%
0.00%
Q2 2022$106,000
-13.8%
7,7300.0%0.00%
Q1 2022$123,000
-27.2%
7,7300.0%0.00%
Q4 2021$169,000
-88.1%
7,730
-75.9%
0.00%
-100.0%
Q1 2021$1,421,000
+10.9%
32,021
+37.1%
0.00%0.0%
Q4 2020$1,281,000
+210.2%
23,354
+29.4%
0.00%
+200.0%
Q3 2020$413,00018,0540.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,037,486$280,250,00019.13%
TANG CAPITAL MANAGEMENT LLC 2,965,485$52,015,0009.58%
Boxer Capital, LLC 1,466,051$25,715,0002.97%
Ghost Tree Capital, LLC 600,000$10,524,0002.75%
BRIDGER MANAGEMENT, LLC 1,529,032$26,819,0002.12%
Cormorant Asset Management, LP 1,700,000$29,818,0002.02%
EcoR1 Capital, LLC 450,000$7,893,0000.73%
UNIVERSITY OF NOTRE DAME DU LAC 171,015$3,000,0000.67%
Virtus ETF Advisers LLC 17,799$312,0000.66%
SPHERA FUNDS MANAGEMENT LTD. 290,001$5,087,0000.46%
View complete list of ROCKET PHARMACEUTICALS INC shareholders